SenzaGen AB (STO:SENZA)
5.44
-0.06 (-1.09%)
At close: Mar 4, 2026
SenzaGen AB Market Cap
SenzaGen AB has a market cap or net worth of 176.84 million as of March 4, 2026. Its market cap has decreased by -3.32% in one year.
Market Cap
176.84M
Enterprise Value
168.93M
Revenue
57.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.44
Market Cap Chart
Since September 21, 2017, SenzaGen AB's market cap has decreased from 669.46M to 176.84M, a decrease of -73.58%. That is a compound annual growth rate of -14.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 176.84M | -1.42% |
| Dec 30, 2025 | 179.38M | -11.88% |
| Dec 30, 2024 | 203.58M | 15.61% |
| Dec 29, 2023 | 176.09M | -39.28% |
| Dec 30, 2022 | 289.98M | 22.62% |
| Dec 30, 2021 | 236.48M | -15.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 134.32B |
| Getinge AB | 54.07B |
| Sectra AB | 37.24B |
| Medicover AB | 32.84B |
| Sprint Bioscience AB | 198.37M |
| Isofol Medical AB | 193.96M |
| Klaria Pharma Holding AB (publ.) | 174.15M |
| Clinical Laserthermia Systems AB | 168.32M |